Hamel Associates, Inc. Johnson & Johnson Transaction History

Hamel Associates, Inc.

  • $324 Million
  • Q3 2024

A detailed history of Hamel Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Hamel Associates, Inc. holds 67,184 shares of JNJ stock, worth $9.75 Million. This represents 3.36% of its overall portfolio holdings.

Number of Shares
67,184
Previous 67,318 0.2%
Holding current value
$9.75 Million
Previous $9.84 Million 10.65%
% of portfolio
3.36%
Previous 3.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$145.48 - $167.38 $19,494 - $22,428
-134 Reduced 0.2%
67,184 $10.9 Million
Q2 2024

Aug 02, 2024
BUY
$144.38 - $157.78 $23,100 - $25,244
160 Added 0.24%
67,318 $9.84 Million
Q1 2024

Apr 23, 2024
BUY
$155.22 - $162.74 $89,251 - $93,575
575 Added 0.86%
67,158 $10.6 Million
Q4 2023

Feb 08, 2024
BUY
$145.6 - $158.88 $58,240 - $63,552
400 Added 0.6%
66,583 $10.4 Million
Q3 2023

Nov 03, 2023
SELL
$155.75 - $174.48 $40,495 - $45,364
-260 Reduced 0.39%
66,183 $10.3 Million
Q2 2023

Aug 08, 2023
BUY
$154.35 - $166.11 $59,424 - $63,952
385 Added 0.58%
66,443 $11 Million
Q1 2023

May 08, 2023
SELL
$151.05 - $180.26 $4,833 - $5,768
-32 Reduced 0.05%
66,058 $10.2 Million
Q4 2022

Feb 06, 2023
SELL
$160.2 - $179.79 $50,463 - $56,633
-315 Reduced 0.47%
66,090 $11.7 Million
Q3 2022

Nov 09, 2022
BUY
$161.33 - $179.52 $65,822 - $73,244
408 Added 0.62%
66,405 $10.8 Million
Q2 2022

Aug 08, 2022
SELL
$168.19 - $186.01 $268,767 - $297,243
-1,598 Reduced 2.36%
65,997 $11.7 Million
Q1 2022

May 06, 2022
SELL
$158.14 - $179.59 $190,242 - $216,046
-1,203 Reduced 1.75%
67,595 $12 Million
Q4 2021

Feb 08, 2022
SELL
$155.93 - $173.01 $102,446 - $113,667
-657 Reduced 0.95%
68,798 $11.8 Million
Q3 2021

Nov 08, 2021
SELL
$161.5 - $179.47 $394,060 - $437,906
-2,440 Reduced 3.39%
69,455 $11.2 Million
Q2 2021

Aug 04, 2021
SELL
$159.48 - $171.07 $129,497 - $138,908
-812 Reduced 1.12%
71,895 $11.8 Million
Q1 2021

May 04, 2021
SELL
$153.07 - $170.48 $171,591 - $191,108
-1,121 Reduced 1.52%
72,707 $12 Million
Q4 2020

Feb 11, 2021
SELL
$137.11 - $157.38 $50,730 - $58,230
-370 Reduced 0.5%
73,828 $11.6 Million
Q3 2020

Nov 09, 2020
SELL
$140.38 - $153.83 $37,902 - $41,534
-270 Reduced 0.36%
74,198 $11 Million
Q2 2020

Aug 10, 2020
BUY
$128.81 - $155.51 $90,295 - $109,012
701 Added 0.95%
74,468 $10.5 Million
Q1 2020

May 07, 2020
BUY
$111.14 - $153.99 $410,773 - $569,147
3,696 Added 5.27%
73,767 $9.67 Million
Q4 2019

Feb 12, 2020
BUY
$127.5 - $146.44 $59,925 - $68,826
470 Added 0.68%
70,071 $10.2 Million
Q3 2019

Nov 12, 2019
SELL
$126.95 - $142.14 $51,414 - $57,566
-405 Reduced 0.58%
69,601 $9.01 Million
Q2 2019

Aug 05, 2019
SELL
$131.15 - $144.24 $28,197 - $31,011
-215 Reduced 0.31%
70,006 $9.75 Million
Q1 2019

May 01, 2019
BUY
$125.72 - $139.79 $429,333 - $477,382
3,415 Added 5.11%
70,221 $9.82 Million
Q4 2018

Feb 08, 2019
BUY
$122.84 - $147.84 $41,765 - $50,265
340 Added 0.51%
66,806 $8.62 Million
Q3 2018

Oct 25, 2018
BUY
$121.58 - $142.88 $15,197 - $17,860
125 Added 0.19%
66,466 $9.18 Million
Q2 2018

Aug 10, 2018
SELL
$119.4 - $131.76 $44,775 - $49,410
-375 Reduced 0.56%
66,341 $8.05 Million
Q1 2018

May 03, 2018
SELL
$125.1 - $148.14 $139,486 - $165,176
-1,115 Reduced 1.64%
66,716 $8.55 Million
Q4 2017

Feb 13, 2018
SELL
$131.22 - $143.62 $93,691 - $102,544
-714 Reduced 1.04%
67,831 $9.48 Million
Q3 2017

Nov 14, 2017
SELL
$129.47 - $135.38 $77,682 - $81,228
-600 Reduced 0.87%
68,545 $8.91 Million
Q2 2017

Aug 11, 2017
BUY
N/A
69,145
69,145 $9.15 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hamel Associates, Inc. Portfolio

Follow Hamel Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email